Xos (XOS) director sells 12,476 shares in July 10b5-1 plan
Rhea-AI Filing Summary
Xos, Inc. (XOS) discloses an amended insider trading report for director Dietmar Ostermann. The amendment corrects prior transaction codes, clarifying that three July 2026 transactions were open-market sales (Code "S") rather than dispositions coded as "D". No other details from the original Form 4 are changed.
The director sold 4,159 shares of common stock on July 15, 2026 at a weighted average price of $2.3025 per share, 4,158 shares on July 16, 2026 at a weighted average of $2.1607, and 4,159 shares on July 17, 2026 at a weighted average of $2.1485. In total, 12,476 shares were sold pursuant to a Rule 10b5-1 trading plan adopted on September 16, 2025. A related footnote states the director’s holdings include 60,584 unvested RSUs.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F5, F3 | 4,159 | $2.1485 | $9K |
| Sale | Common Stock F1, F4, F3 | 4,158 | $2.1607 | $9K |
| Sale | Common Stock F1, F2, F3 | 4,159 | $2.3025 | $10K |
Footnotes (5)
- F1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2025.
- F2. Represents weighted average sales price. The shares were sold at prices ranging from $2.23 to $2.34. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F3. Includes 60,584 unvested RSUs.
- F4. Represents weighted average sales price. The shares were sold at prices ranging from $2.12 to $2.32. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F5. Represents weighted average sales price. The shares were sold at prices ranging from $2.11 to $2.18. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Form 4 regulatory
weighted average sales price financial
unvested RSUs financial
open market market
FAQ
What does the amended Form 4/A report for XOS insider Dietmar Ostermann?
Why was this Form 4/A amendment filed for XOS?
Were the July 2026 XOS insider sales under a 10b5-1 trading plan?
How many unvested RSUs does the XOS director still have according to this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.